(1 - 4 von 7
)
Mick Farrell | Benzinga
www.benzinga.com
ResMed Inc. (NYSE: RMD), a provider of treatment for sleep-disordered breathing, announced on Monday it has agreed to acquire Brightree, ...
sortiert nach Relevanz / Datum